Cargando…
Hepcidin as a Diagnostic Biomarker in Anaemic Lung Cancer Patients
SIMPLE SUMMARY: Lung cancer is the leading cause of cancer-related deaths, with a low overall survival rate. Anaemia is one of the most common cancer side effects, reducing the patient’s survival time among other things. Lung cancer patients have the highest incidence of anaemia, with 50–70% of pati...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818260/ https://www.ncbi.nlm.nih.gov/pubmed/36612220 http://dx.doi.org/10.3390/cancers15010224 |